Neoadjuvant Herceptin in Patients With Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00133796
Recruitment Status : Terminated (Closed to accrual 4/19/2006 / Study doesn't qualify for reporting.)
First Posted : August 24, 2005
Last Update Posted : February 7, 2017
Genentech, Inc.
Information provided by (Responsible Party):
Mothaffar Rimawi, Baylor Breast Care Center

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2005
  Actual Study Completion Date : April 2007